US L-carnosine market is estimated to grow at a CAGR of around 6.0% during the forecast period. The factors that contribute to the market growth include a significant prevalence of Autistic Spectrum Disorders (ASD) and chronic diseases, such as diabetes and CVD. In addition, significant awareness regarding dietary supplements consumption in the country further gives a boost to the regional growth of the market. As per the Centers for Disease Control and Prevention (CDC), nearly 1 in 6 (17%) children under the age group of 3–17 years were diagnosed with a developmental disability in the US during 2009-2017. This comprised blindness, autism, cerebral palsy, attention-deficit/hyperactivity disorder, and more. This may increase the need for nutritional supplements for the treatment of ASD among children.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/us-l-carnosine-market
L-Carnosine is considered as the first dietary supplement that supports in improving cognitive and behavioral symptoms. Docosahexaenoic acid (DHA) improves learning and memory abilities. The research by Dr. Chez, a pediatric neurologist suggest that L-Carnosine may improve auditory processing, receptive language, socialization, and awareness of surroundings. Therefore, L-Carnosine is being recommended by doctors as a supplement for the treatment of ASD patients. It may augment neurological function or act as a neuroprotective peptide. It may support autistic children in a range of ways, primarily centering on the child’s behavior, and language skills, and may enhance nervous system function. It also acts as a strong antioxidant and free radical scavenger.
The US L-carnosine market is segmented on the basis of application and geography. Based on the application, the market is segmented into autism, diabetes support, skin support, CVD support, joint support, and others, which include digestion support, Parkinson’s disease, and Alzheimer’s disease. The skin support segment is estimated to contribute a prominent share in the global market. The major benefits of L-carnosine based products for skincare include the protection of skin from UV rays of sunlight, repairing of sunburn, wound healing support, proper moisturization & hydration, and restoration of barrier function.
Some key players in operating the US L-carnosine market include Kirkman Group, Inc., Charkit Chemical Company LLC, and Klaire Labs. These market players are adopting strategies including mergers and acquisitions, product launches, and partnerships and collaborations, to gain a competitive advantage. For instance, in July 2019, Charkit Chemical Company LLC acquired Custom Ingredients, a manufacturer of specialty ingredients, and CA Specialties in the personal care market. The acquisition aimed to increase access to the market.
US L-Carnosine Market- Segmentation
By Application
- Autism
- Diabetes
- Skin Support
- Cardiovascular Support
- Joint Support
- Others
A full report of US L-Carnosine Market is available at: https://www.omrglobal.com/industry-reports/us-l-carnosine-market